Market Cap (In HKD)
2.12 Billion
Revenue (In HKD)
137.62 Million
Net Income (In HKD)
-1.96 Billion
Avg. Volume
1 Million
- Currency
- HKD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 5.57-18.26
- PE
- -
- EPS
- -
- Beta Value
- 0.0
- ISIN
- KYG2606C1006
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Ms. Lele Zhang
- Employee Count
- -
- Website
- https://www.cutiatx.com
- Ipo Date
- 2023-06-12
- Details
- Cutia Therapeutics operates as a biopharmaceutical company that develops a dermatology platform for skin and scalp diseases. The company focuses on the dermatology treatment and care therapeutic areas, including localized adipose accumulation management medication, scalp diseases and care, skin diseases and care, and topical anesthesia. The company was incorporated in 2019 and is based in Shanghai, China with additional offices in Beijing, Wuxi and Hong Kong.
More Stocks
-
0543
-
ELO
-
DATSDatChat, Inc.
DATS
-
STOVEKRAFTStove Kraft Limited
STOVEKRAFT
-
NAHARCAP
-
SESGSES S.A.
SESG
-
TWR
-
NAHNAHL Group Plc
NAH